TNF and Alzheimer disease: In conclusion, we provide strong evidence for inflammation-driven activation of TNF-mediated necroptosis in CA1-2 hippocampal neurons in the post-mortem AD brain and propose that targeting the necroptosis pathway could hold great promise for inhibiting neurodegeneration.